ISG15 Activators belong to a specific category of molecules that promote the activation of ISG15, a ubiquitin-like modifier. ISG15, standing for Interferon-Stimulated Gene 15, is a protein that has a crucial role in the innate immune response to viral infections. It is one of the many genes that get upregulated in response to interferon (IFN) signaling, a type of cellular defense mechanism against pathogenic invasions. When a cell encounters a viral threat, interferons are released and bind to their respective receptors on the cell's surface. This binding leads to a signaling cascade that eventually results in the transcription of various interferon-stimulated genes (ISGs), including ISG15. Once produced, ISG15 can be covalently attached to target proteins in a process called ISGylation, which alters the function of the tagged proteins, usually to inhibit viral processes or propagation.
ISG15 Activators are molecules that stimulate this pathway, leading to an increased presence or activity of ISG15 in the cell. The mechanisms through which these activators operate can be diverse. Some might enhance the expression of ISG15 directly by modulating the transcriptional machinery of the cell, while others could indirectly bolster ISG15 action by targeting other components of the interferon signaling pathway. The overall effect, however, is an enhanced ISG15-mediated response. Given the importance of ISG15 in antiviral defenses, understanding the biology and biochemistry of its activators can provide valuable insights into the intricate cellular strategies designed to ward off viral threats.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) mimics double-stranded RNA, a viral replication intermediate. This activates cellular pattern recognition receptors leading to the upregulation of antiviral genes, including ISG15. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
Resiquimod is a TLR7/8 agonist. Upon activation, these toll-like receptors trigger pathways that induce the expression of interferon-stimulated genes, including ISG15. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is a TLR7 agonist. By activating TLR7, it leads to the induction of various antiviral genes, including ISG15, as part of the immune response. | ||||||
2′,3′-cGAMP | 1441190-66-4 | sc-507484 | 10 mg | $1800.00 | ||
2'3'-cGAMP is a cyclic dinucleotide that acts as a second messenger in the STING pathway, which senses cytosolic DNA. Activation of this pathway induces the expression of ISG15 among other genes. | ||||||
DMXAA | 117570-53-3 | sc-207592 sc-207592A | 5 mg 25 mg | $129.00 $590.00 | 1 | |
DMXAA is an analog of xanthenone and acts as a STING agonist. By activating the STING pathway, DMXAA can induce the expression of various antiviral genes, including ISG15. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
Gardiquimod is a TLR7 agonist. It can activate TLR7 leading to the induction of interferon-stimulated genes, one of which is ISG15. | ||||||